2018 SPS Resources
- Assessment of Multiple Positive Controls in the Langendorff Isolated Heart Assay and How They Translate to Whole Animal (Available in The Source℠)
- Can Cardiovascular Liabilities Be Detected Earlier in Drug Development? Assessing the Translation of Tyrosine Kinase Inhibitors from Cardiomyocytes and Isolated Hearts to Whole Animal (Available in The Source℠)
- Cardiovascular Assessments in Juvenile Large Animals Using Jacketed Telemetry: Background Data and The Effects of Heart Rate on QT Correction (Available in The Source℠)
- Closing the Preclinical Gap to Derisk the Potential for Serotonin Toxicity: Was that a Twitch I See?
- The Impact of the Functional Observational Battery and Irwin Tests in CNS Safety Pharmacology: Results of an Industry Survey
- Implementation of DSI FinePointe® Whole Body Plethysmography Method in Freely Moving Rats
- Investigation of Orthostatic Hypotension in Conscious Large Animals within the Context of Regulatory Toxicology Studies (Available in The Source℠)
- Is the Current Non-Clinical Drug Development Safety Paradigm Effective for Assessing Cardiovascular Liabilities?
- Metabolic Regulation of the Electrophysiology and Contractility of Induced Pluripotent Stem Call-Derived Cardiomyocytes (iPSC-CM) (Available in The Source℠)
- Potency of Late-Nav1.5 Current Inhibition Depends on the Agonist Used to Augment It
- Surface Lead EEGs: Will It Stick? (Available in The Source℠)
- Validation of Gluteus Medius Muscle Electromyographic (EMG) Recording by Telemetry in Socialized Large Animals (Available in The Source℠)